Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Nasopharyngeal carriage of invasive pneumococcal serotypes during childhood community-acquired alveolar pneumonia is associated with specific clinical presentation.

Faingelernt Y, Dagan R, Givon-Lavi N, Ben-Shimol S, Bar-Ziv J, Greenberg D.

J Infect Dis. 2019 Oct 5. pii: jiz513. doi: 10.1093/infdis/jiz513. [Epub ahead of print]

PMID:
31586205
2.

Characterization of acute otitis media otopathogens before the introduction of the pneumococcal conjugated vaccine into the national immunization program in Poland.

Górska-Kot A, Greenberg D, Gastoł K, Zieliński A, Givon-Lavi N.

Int J Pediatr Otorhinolaryngol. 2019 Aug 31;127:109666. doi: 10.1016/j.ijporl.2019.109666. [Epub ahead of print]

PMID:
31491733
3.

Urine dipstick low sensitivity for UTI diagnosis in febrile infants *.

Lendner I, Justman N, Givon-Lavi N, Maimon MS, Kestenbaum I, Ben-Shimol S.

Infect Dis (Lond). 2019 Oct;51(10):764-771. doi: 10.1080/23744235.2019.1652339. Epub 2019 Aug 16.

PMID:
31418615
4.

Use of Chest Radiography Examination as a Probe for PCV Impact on Lower Respiratory Tract Infections in Young Children.

Ben-Shimol S, Dagan R, Givon-Lavi N, Avital D, Bar-Ziv J, Greenberg D.

Clin Infect Dis. 2019 Aug 15. pii: ciz768. doi: 10.1093/cid/ciz768. [Epub ahead of print]

PMID:
31414125
5.

Stable dynamics of pneumococcal carriage over a decade in the pre-PCV era.

Wagner BG, Althouse BM, Givon-Lavi N, Hu H, Dagan R.

Vaccine. 2019 Sep 3;37(37):5625-5629. doi: 10.1016/j.vaccine.2019.07.077. Epub 2019 Aug 2.

6.

Interaction With Nontypeable Haemophilus influenzae Alters Progression of Streptococcus pneumoniae From Colonization to Disease in a Site-Specific Manner.

Lewnard JA, Givon-Lavi N, Dagan R.

J Infect Dis. 2019 Sep 13;220(8):1367-1376. doi: 10.1093/infdis/jiz312.

PMID:
31233130
7.

Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.

Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M, Benisty R, Givon-Lavi N, Hawkins PA, Cornick JE, Kwambana-Adams B, Law PY, Ho PL, Antonio M, Everett DB, Dagan R, von Gottberg A, Klugman KP, McGee L, Breiman RF, Bentley SD; Global Pneumococcal Sequencing Consortium.

Lancet Infect Dis. 2019 Jul;19(7):759-769. doi: 10.1016/S1473-3099(19)30297-X. Epub 2019 Jun 10.

8.

Incidence of respiratory syncytial virus bronchiolitis in hospitalized infants born at 33-36 weeks of gestational age compared with those born at term: a retrospective cohort study.

Greenberg D, Dagan R, Shany E, Ben-Shimol S, Givon-Lavi N.

Clin Microbiol Infect. 2019 Jun 7. pii: S1198-743X(19)30288-5. doi: 10.1016/j.cmi.2019.05.025. [Epub ahead of print]

PMID:
31181285
9.

Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis.

Ben-Shimol S, Givon-Lavi N, Leibovitz E, Greenberg D, Dagan R.

Vaccine. 2019 Jan 3;37(1):1-6. doi: 10.1016/j.vaccine.2018.11.054. Epub 2018 Nov 26.

PMID:
30497832
10.

Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of Streptococcus pneumoniae meningitis in children aged 5 years or younger, Israel, 2004 to 2016.

Ben-Shimol S, Givon-Lavi N, Greenberg D, Stein M, Megged O, Bar-Yochai A, Negari S, Dagan R, On Behalf Of The Israel Bacteremia And Meningitis Active Surveillance Group.

Euro Surveill. 2018 Nov;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.1800081. No abstract available.

11.

Association Between the Decline in Pneumococcal Disease in Unimmunized Adults and Vaccine-Derived Protection Against Colonization in Toddlers and Preschool-Aged Children.

Weinberger DM, Pitzer VE, Regev-Yochay G, Givon-Lavi N, Dagan R.

Am J Epidemiol. 2019 Jan 1;188(1):160-168. doi: 10.1093/aje/kwy219.

12.

Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccines implementation in young children.

Danino D, Givon-Lavi N, Ben-Shimol S, Greenberg D, Dagan R.

Clin Infect Dis. 2018 Oct 29. doi: 10.1093/cid/ciy926. [Epub ahead of print]

PMID:
30371763
13.

The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis.

Balsells E, Dagan R, Yildirim I, Gounder PP, Steens A, Muñoz-Almagro C, Mameli C, Kandasamy R, Givon Lavi N, Daprai L, van der Ende A, Trzciński K, Nzenze SA, Meiring S, Foster D, Bulkow LR, Rudolph K, Valero-Rello A, Ducker S, Vestrheim DF, von Gottberg A, Pelton SI, Zuccotti G, Pollard AJ, Sanders EAM, Campbell H, Madhi SA, Nair H, Kyaw MH.

J Infect. 2018 Nov;77(5):368-378. doi: 10.1016/j.jinf.2018.06.004. Epub 2018 Jun 30.

PMID:
29964140
14.

Dynamics of Severe and Non-severe Invasive Pneumococcal Disease in Young Children in Israel Following PCV7/PCV13 Introduction.

Glikman D, Dagan R, Barkai G, Averbuch D, Guri A, Givon-Lavi N, Ben-Shimol S; Israel Bacteremia and Meningitis Active Surveillance Group.

Pediatr Infect Dis J. 2018 Oct;37(10):1048-1053. doi: 10.1097/INF.0000000000002100.

PMID:
29750768
15.

A toddler PCV booster dose following 3 infancy priming doses increases circulating serotype-specific IGG levels but does not increase protection against carriage.

Dagan R, Ben-Shimol S, Simell B, Greenberg D, Porat N, Käyhty H, Givon-Lavi N.

Vaccine. 2018 May 11;36(20):2774-2782. doi: 10.1016/j.vaccine.2018.04.007. Epub 2018 Apr 11.

PMID:
29655626
16.

Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.

Rokney A, Ben-Shimol S, Korenman Z, Porat N, Gorodnitzky Z, Givon-Lavi N, Ron M, Agmon V, Dagan R, Valinsky L.

Emerg Infect Dis. 2018 Mar;24(3):453-461. doi: 10.3201/eid2403.170769.

17.

Pneumococcal Phenotype and Interaction with Nontypeable Haemophilus influenzae as Determinants of Otitis Media Progression.

Lewnard JA, Givon-Lavi N, Tähtinen PA, Dagan R.

Infect Immun. 2018 May 22;86(6). pii: e00727-17. doi: 10.1128/IAI.00727-17. Print 2018 Jun.

18.

Pan-serotype Reduction in Progression of Streptococcus pneumoniae to Otitis Media After Rollout of Pneumococcal Conjugate Vaccines.

Lewnard JA, Givon-Lavi N, Weinberger DM, Lipsitch M, Dagan R.

Clin Infect Dis. 2017 Nov 13;65(11):1853-1861. doi: 10.1093/cid/cix673.

19.

Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.

Ben-Shimol S, Givon-Lavi N, Grisaru-Soen G, Megged O, Greenberg D, Dagan R; Israel Bacteremia and Meningitis Active Surveillance Group.

Vaccine. 2018 Aug 28;36(36):5477-5484. doi: 10.1016/j.vaccine.2017.05.059. Epub 2017 Jun 1.

PMID:
28579230
20.

Incidence of typically Severe Primary Immunodeficiency Diseases in Consanguineous and Non-consanguineous Populations.

Broides A, Nahum A, Mandola AB, Rozner L, Pinsk V, Ling G, Yerushalmi B, Levy J, Givon-Lavi N.

J Clin Immunol. 2017 Apr;37(3):295-300. doi: 10.1007/s10875-017-0378-6. Epub 2017 Mar 16.

PMID:
28299599
21.

PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children.

Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gruber WC, Scott DA.

Vaccine. 2017 Feb 7;35(6):945-950. doi: 10.1016/j.vaccine.2016.12.052. Epub 2017 Jan 11.

PMID:
28087146
22.

Nasopharyngeal Pneumococcal Carriage During Childhood Community-Acquired Alveolar Pneumonia: Relationship Between Specific Serotypes and Coinfecting Viruses.

Greenberg D, Givon-Lavi N, Faingelernt Y, Ben-Shimol S, Avni YS, Bar-Ziv J, Dagan R.

J Infect Dis. 2017 Apr 1;215(7):1111-1116. doi: 10.1093/infdis/jiw613.

PMID:
28011920
23.

Cocontribution of Rotavirus and Pneumococcal Conjugate Vaccines to the Reduction of Pediatric Hospital Visits in Young Children.

Ben-Shimol S, Givon-Lavi N, Greenberg D, Dagan R.

J Pediatr. 2017 Mar;182:253-259.e2. doi: 10.1016/j.jpeds.2016.11.041. Epub 2016 Dec 8.

PMID:
27939127
24.

Adhesion and invasion of Streptococcus pneumoniae to primary and secondary respiratory epithelial cells.

Novick S, Shagan M, Blau K, Lifshitz S, Givon-Lavi N, Grossman N, Bodner L, Dagan R, Mizrachi Nebenzahl Y.

Mol Med Rep. 2017 Jan;15(1):65-74. doi: 10.3892/mmr.2016.5996. Epub 2016 Dec 6.

25.

Using Pneumococcal Carriage Data to Monitor Postvaccination Changes in the Incidence of Pneumococcal Otitis Media.

Flasche S, Givon-Lavi N, Dagan R.

Am J Epidemiol. 2016 Nov 1;184(9):652-659. Epub 2016 Oct 15.

26.

Density, Serotype Diversity, and Fitness of Streptococcus pneumoniae in Upper Respiratory Tract Cocolonization With Nontypeable Haemophilus influenzae.

Lewnard JA, Huppert A, Givon-Lavi N, Pettigrew MM, Regev-Yochay G, Dagan R, Weinberger DM.

J Infect Dis. 2016 Nov 1;214(9):1411-1420. Epub 2016 Aug 17.

27.

Impact of PCV7/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD.

Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Miron D, Aviner S, Dagan R; Israel Bacteremia and Meningitis Active Surveillance Group.

Vaccine. 2016 Aug 31;34(38):4543-4550. doi: 10.1016/j.vaccine.2016.07.038. Epub 2016 Jul 27.

PMID:
27475471
28.

Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.

Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gruber WC, Scott DA.

Vaccine. 2016 Aug 5;34(36):4313-20. doi: 10.1016/j.vaccine.2016.06.075. Epub 2016 Jul 12.

PMID:
27422342
29.

Comparison of early onset sepsis and community-acquired late onset sepsis in infants less than 3 months of age.

Bulkowstein S, Ben-Shimol S, Givon-Lavi N, Melamed R, Shany E, Greenberg D.

BMC Pediatr. 2016 Jul 7;16:82. doi: 10.1186/s12887-016-0618-6.

30.

Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.

Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R.

Clin Infect Dis. 2016 Sep 1;63(5):611-8. doi: 10.1093/cid/ciw347. Epub 2016 May 25.

PMID:
27225239
31.

The impact of pneumococcal conjugate vaccines on carriage of and disease caused by Streptococcus pneumoniae serotypes 6C and 6D in southern Israel.

Porat N, Benisty R, Givon-Lavi N, Trefler R, Dagan R.

Vaccine. 2016 May 27;34(25):2806-12. doi: 10.1016/j.vaccine.2016.04.043. Epub 2016 Apr 23.

PMID:
27113163
32.

Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.

Leshem E, Givon-Lavi N, Tate JE, Greenberg D, Parashar UD, Dagan R.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S155-60. doi: 10.1093/cid/civ1012.

PMID:
27059350
33.

Anaphylactic reactions in adult patients in Southern Israel.

Hananashvili I, Givon-Lavi N, Bartal C, Broides A.

Asian Pac J Allergy Immunol. 2016 Mar;34(1):44-50. doi: 10.12932/AP0521.34.1.2016.

34.

Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage.

Lewnard JA, Givon-Lavi N, Huppert A, Pettigrew MM, Regev-Yochay G, Dagan R, Weinberger DM.

J Infect Dis. 2016 May 15;213(10):1596-605. doi: 10.1093/infdis/jiv761. Epub 2015 Dec 23.

35.

Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.

Ben-Shimol S, Givon-Lavi N, Greenberg D, Dagan R.

Hum Vaccin Immunother. 2016;12(2):268-76. doi: 10.1080/21645515.2015.1095414.

36.

Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.

Greenberg D, Givon-Lavi N, Ben-Shimol S, Ziv JB, Dagan R.

Vaccine. 2015 Aug 26;33(36):4623-9. doi: 10.1016/j.vaccine.2015.06.062. Epub 2015 Jun 23.

PMID:
26116251
37.

Differences in Norovirus-Associated Hospital Visits Between Jewish and Bedouin Children in Southern Israel.

Leshem E, Givon-Lavi N, Vinjé J, Gregoricus N, Parashar U, Dagan R.

Pediatr Infect Dis J. 2015 Sep;34(9):1036-8. doi: 10.1097/INF.0000000000000786.

PMID:
26107344
38.

Differential impact of pneumococcal conjugate vaccines on bacteremic pneumonia versus other invasive pneumococcal disease.

Ben-Shimol S, Greenberg D, Hazan G, Givon-Lavi N, Gottesman G, Grisaru-Soen G, Dagan R; Israeli Bacteremia and Meningitis Active Surveillance Group.

Pediatr Infect Dis J. 2015 Apr;34(4):409-16. doi: 10.1097/INF.0000000000000604.

PMID:
25764098
39.

Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.

Givon-Lavi N, Ben-Shimol S, Cohen R, Greenberg D, Dagan R.

Vaccine. 2015 Apr 15;33(16):1934-40. doi: 10.1016/j.vaccine.2015.02.062. Epub 2015 Mar 3.

PMID:
25744226
40.

The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012.

Levine H, Kopel E, Anis E, Givon-Lavi N, Dagan R.

Euro Surveill. 2015 Feb 19;20(7):3-10. No abstract available.

41.

Seasonality of both bacteremic and nonbacteremic pneumonia coincides with viral lower respiratory tract infections in early childhood, in contrast to nonpneumonia invasive pneumococcal disease, in the pre-pneumococcal conjugate vaccine era.

Ben-Shimol S, Greenberg D, Hazan G, Shemer-Avni Y, Givon-Lavi N, Dagan R.

Clin Infect Dis. 2015 May 1;60(9):1384-7. doi: 10.1093/cid/civ023. Epub 2015 Jan 16.

PMID:
25595749
42.

Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.

Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA.

J Infect Dis. 2015 Apr 1;211(7):1144-53. doi: 10.1093/infdis/jiu576. Epub 2014 Oct 29.

PMID:
25355940
43.

Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.

Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R.

Clin Infect Dis. 2014 Dec 15;59(12):1724-32. doi: 10.1093/cid/ciu683. Epub 2014 Aug 25.

PMID:
25159581
44.

Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization.

Juergens C, Patterson S, Trammel J, Greenberg D, Givon-Lavi N, Cooper D, Gurtman A, Gruber WC, Scott DA, Dagan R.

Clin Vaccine Immunol. 2014 Sep;21(9):1277-81. doi: 10.1128/CVI.00172-14. Epub 2014 Jul 2.

45.

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance.

Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S, Miron D, Dagan R.

Vaccine. 2014 Jun 5;32(27):3452-9. doi: 10.1016/j.vaccine.2014.03.065. Epub 2014 Mar 30.

PMID:
24690148
46.

Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study.

Bamberger EE, Ben-Shimol S, Abu Raya B, Katz A, Givon-Lavi N, Dagan R, Srugo I; Israeli Pediatric Bacteremia and Meningitis Group.

Pediatr Infect Dis J. 2014 May;33(5):477-81. doi: 10.1097/INF.0000000000000193.

PMID:
24445822
47.

Epidemiological trends and patterns of antimicrobial resistance of Shigella spp. isolated from stool cultures in two different populations in Southern Israel.

Peleg I, Givon-Lavi N, Leibovitz E, Broides A.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):287-91. doi: 10.1016/j.diagmicrobio.2013.12.005. Epub 2013 Dec 14.

PMID:
24418369
48.

Anaphylactic reactions requiring hospitalization among Bedouin and Jewish children in southern Israel.

Elkarat S, Leibovitz E, Givon-Lavi N, Gershon E, Broides A.

J Investig Allergol Clin Immunol. 2013;23(5):363-4. No abstract available.

49.

Increased risk for respiratory syncytial virus-associated, community-acquired alveolar pneumonia in infants born at 31-36 weeks of gestation.

Greenberg D, Dagan R, Shany E, Bar-Ziv J, Givon-Lavi N.

Pediatr Infect Dis J. 2014 Apr;33(4):381-6. doi: 10.1097/INF.0000000000000130.

PMID:
24145171
50.

Influenza A/H1N1 in pediatric oncology patients.

Dotan A, Ben-Shimol S, Fruchtman Y, Avni-Shemer Y, Kapelushnik J, Ben-Harush M, Givon-Lavi N, Leibovitz E, Greenberg D.

J Pediatr Hematol Oncol. 2014 Jul;36(5):e271-4. doi: 10.1097/MPH.0000000000000043.

PMID:
24136021

Supplemental Content

Loading ...
Support Center